首页> 外国专利> New nucleic acid encoding human receptor for steroid or sterol, useful for identifying modulators, for treating e.g. osteoporosis and prostatic hypertrophy

New nucleic acid encoding human receptor for steroid or sterol, useful for identifying modulators, for treating e.g. osteoporosis and prostatic hypertrophy

机译:编码用于类固醇或固醇的人类受体的新核酸,可用于鉴定调节剂,例如用于治疗骨质疏松和前列腺肥大

摘要

Nucleic acid (I) comprising: (a) a human sequence of 7093 or 7307 base pairs given in the specification; (b) a sequence equivalent to (a) within the degeneracy of the genetic code; or (c) a sequence that hybridizes to (a) under stringent conditions, is new. Independent claims are also included for: (1) nucleic acid (Ia) that encodes polypeptides of 2014 amino acids (aa) or 2041 aa; (2) polypeptides (II) encoded by (I) or (Ia); (3) antibodies (Ab) against (II); (4) vector containing at least one copy of (I) or (Ia); (5) cells transfected with (I), (Ia) or the vector; (6) test system for identifying (M1) effectors of (II) or inhibitors of the kinase function of (II); and (7) preparing a pharmaceutical composition using (M1) to identify a modulator of (II) activity, then formulating this conventionally.
机译:核酸(I),其包含:(a)说明书中给出的7093或7307个碱基对的人序列; (b)在遗传密码的简并性范围内与(a)等效的序列; (c)在严格条件下与(a)杂交的序列是新的。还包括以下方面的独立权利要求:(1)编码2014氨基酸(aa)或2041aa的多肽的核酸(Ia); (2)由(I)或(Ia)编码的多肽(II); (3)针对(II)的抗体(Ab); (4)载体,其包含至少一个拷贝的(I)或(Ia); (5)用(I),(Ia)或载体转染的细胞; (6)用于鉴定(II)的(M1)个效应子或(II)的激酶功能的抑制剂的测试系统; (7)使用(M1)制备药物组合物以鉴定(II)活性的调节剂,然后常规配制。

著录项

  • 公开/公告号DE10120337A1

    专利类型

  • 公开/公告日2002-11-07

    原文格式PDF

  • 申请/专利权人 SCHERING AG;

    申请/专利号DE2001120337

  • 申请日2001-04-26

  • 分类号C07K14/47;C12N9/12;

  • 国家 DE

  • 入库时间 2022-08-22 00:26:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号